OSSIO, Inc., an orthopedic fixation technology company, today announced that it has received a contract with Vizient, Inc., making the company’s portfolio of bio-integrative OSSIOfiber products available at negotiated pricing to health care providers in Vizient’s group purchasing organization (GPO) under a three-year contract starting March 1.

OSSIO’s contract with Vizient covers the entire OSSIOfiber Intelligent Bone Regeneration Technology portfolio currently commercialized and cleared by the U.S. Food and Drug Administration (FDA). These products include sterile, disposable instrument kits:

  • OSSIOfiberHammertoe Fixation System– 10-degree and straight implants in 2.5mm, 2.9mm and 3.2mm sizes.
  • OSSIOfiberTrimmable Fixation Nails– Solid-core in 2.4mm and 4.0mm sizes and cannulated in 3.0mm and 4.0mm sizes.
  • OSSIOfiberCompression Screws– Headless, cannulated, partially threaded configurations in 4.0mm diameter and lengths from 26–60mm.

“Our contract with Vizient enables increased access through negotiated pricing to OSSIOfiber technology for thousands of U.S. hospitals and surgery centers,” said OSSIO Chief Commercial and Operating Officer Brennan Marilla. “Our strong and bio-integrative fixation products provide patients durable fixation and natural healing, which addresses many of the complications and costs associated with permanent metal fixation, including secondary hardware removal procedures.”

“We are thrilled to receive a contract from Vizient for OSSIOfiber implants,” Marilla added, “and hope to help Vizient members care for their patients through the adoption of this novel technology.”

OSSIOfiber Intelligent Bone Regeneration Technology is a breakthrough in fixation material that provides the first credible solution to the shortcomings of permanent metal hardware, conventional resorbable and allograft implants, and combines unparalleled mechanical strength and natural bone healing in a non-permanent implant. Made from a proprietary natural mineral fiber matrix, its bio-integrative material properties provide surgeons with a more biologically friendly way to restore patient stability and mobility while leaving nothing permanent behind.

Beginning March 1, OSSIOfiber products are available to all members of Vizient at contracted pricing. Vizient is the largest member-driven health care performance improvement company in the country with a diverse membership and customer base including academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers.

OSSIOfiber Intelligent Bone Regeneration Technology can address many surgical applications through the manufacturing of endless implant designs, including nails, screws, staples, anchors and plates. The company intends to pursue multiple applications in the distal extremity, trauma, sports, reconstruction, pediatrics and spine segments.

Source: Company Press Release